Upload
dorcas-palmer
View
212
Download
0
Embed Size (px)
Citation preview
Information Investment Subcommittee Meeting
EVM SLIDE ONLY
December 20, 2007
2
EVM Metrics – FY 2007 Q4 Cumulative
Note: $ in thousands.
Investment TitlePlanned Cost
(BCWS)Actual Cost
(ACWP)Earned Value
(BCWP)Cost Variance
% (CV)
Schedule Variance %
(SV)
CAMDBS $15,844 $15,999 $15,621 -2.4% -1.4%
ICIS $33,631 $32,974 $33,608 1.9% -0.1%
eRulemaking $38,152 $34,719 $33,956 -2.3% -11.0%
CDX $33,040 $32,239 $32,879 1.9% -0.5%
SDMS $46,685 $43,424 $43,368 -0.1% -7.1%
FinRS $92,198 $70,991 $69,690 -1.9% -24.4%
ECMS $8,076 $8,493 $8,543 0.6% 5.8%
EPASS $10,563 $10,759 $10,563 -1.9% 0.0%
PRISM $9,745 $8,656 $8,639 -0.2% -11.4%
STORET $23,851 $23,003 $23,191 0.8% -2.8%
EPA PORTFOLIO TOTALS $311,785 $281,257 $280,058 -0.4% -10.2%
3
EVM and Portfolio Variance FY 2007 Q4 – Cumulative Variance Report
• 10 investments reporting Earned Value. 7 investments are within 10% cost and schedule variance
• 3 investments are not within 10% variance– eRulemaking: -11.0% schedule variance due to CR and delay in receiving
funds
– FinRS: -24.4% schedule variance due to contract award delay and bid protest
– PRISM: -11.4% schedule variance due to the planning for PRIA II legislation
• Portfolio performance outside acceptable variance
Cost Variance (CV) = -0.4%
Schedule Variance (SV) = -10.2%